安能物流(09956.HK)獲董事會主席兼主要股東王擁軍增持20萬股
格隆匯12月16日丨安能物流(09956.HK)公吿,內容有關公司董事會主席、執行董事兼公司主要股東王擁軍增持公司股權。
董事會獲王擁軍吿知,於2021年12月14日及2021年12月15日,Double Brighten Creation Limited於市場上進一步增持合共20萬股公司普通股股份,總代價約為175.83萬港元(平均價格約為每股股份8.79135港元)。Double Brighten 為以王擁軍設立的信託持有股份的投資工具。增持事項充分體現主席對公司未來前景的信心以及對於公司持續發展的支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.